RT Journal Article
SR Electronic
T1 Confirmation of an Inverse Relationship between Bioaerosol Count and Influenza-like Illnesses, Including COVID-19. On the Contribution of Mold Spores
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.07.21251322
DO 10.1101/2021.02.07.21251322
A1 Shah, Richa B.
A1 Shah, Rachna D.
A1 Retzinger, Damien G.
A1 Retzinger, Andrew C.
A1 Retzinger, Deborah A.
A1 Retzinger, Gregory S.
YR 2021
UL http://medrxiv.org/content/early/2021/02/16/2021.02.07.21251322.abstract
AB Data from Chicago confirm the end of flu season coincides with the beginning of pollen season. The end of flu season also coincides with onset of seasonal aerosolization of mold spores. Overall, the data suggest bioaerosols, especially mold spores, compete with viruses for a shared receptor, with the periodicity of influenza-like illnesses, including COVID-19, a consequence of seasonal factors that influence aerosolization of competing species.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by departmental funding from the Northwestern University Department of Pathology.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All patient data is freely available from the Chicago Department of Public Health website. https://www.chicago.gov/city/en/sites/covid19/home/covid-dashboard.html and https://data.cityofchicago.org/browse?limitTo=datasets&sortBy=alpha&tags=covid-19All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this published article and its supplementary information files.